Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
374Water | SCWO | Nov 19, 2024 | 1.00 | -2.43 |
3D Systems | DDD | Nov 19, 2024 | 3.01 | +1.69 |
3M | MMM | Nov 19, 2024 | 128.19 | -1.52 |
4D Molecular Therapeutics | FDMT | Nov 19, 2024 | 8.67 | +4.21 |
51Talk Online Education Group ADR | COE | Nov 19, 2024 | 15.53 | +5.29 |
5E Advanced Materials | FEAM | Nov 19, 2024 | 0.44 | -0.99 |
60 Degrees Pharmaceuticals | SXTP | Nov 19, 2024 | 0.92 | +5.75 |
7-10 Yr Trsy Bear 3X Direxion | TYO | Nov 19, 2024 | 14.38 | -0.41 |
7-10 Yr Trsy Bull 3X Direxion | TYD | Nov 19, 2024 | 24.59 | +0.70 |
7-10 Yr Trsy Ishares | IEF | Nov 19, 2024 | 93.73 | +0.21 |
89bio | ETNB | Nov 19, 2024 | 7.99 | +0.19 |
8x8 | EGHT | Nov 19, 2024 | 2.69 | -2.54 |
908 Devices | MASS | Nov 19, 2024 | 2.48 | +5.08 |
99 Acquisition Group | NNAGU | Nov 19, 2024 | 10.60 | 0.00 |
9F ADR | JFU | Nov 19, 2024 | 1.19 | -7.03 |
A SPAC II Acquisition | ASCB | Nov 19, 2024 | 11.19 | 0.00 |
A-Mark Precious Metals | AMRK | Nov 19, 2024 | 30.09 | +4.15 |
a.k.a Brands | AKA | Nov 19, 2024 | 19.00 | -2.26 |
A.O Smith | AOS | Nov 19, 2024 | 71.41 | -1.03 |
A10 Networks | ATEN | Nov 19, 2024 | 16.40 | +0.31 |
A2Z Cust2Mate Solutions | AZ | Nov 19, 2024 | 6.65 | -0.30 |
AA Mission Acquisition | AAM | Nov 19, 2024 | 10.05 | 0.00 |
AAA - A Rated Corporate Bond Ishares | QLTA | Nov 19, 2024 | 47.49 | +0.23 |
Aadi Bioscience | AADI | Nov 19, 2024 | 2.21 | +2.79 |
AAON | AAON | Nov 19, 2024 | 131.16 | -0.14 |
AAR | AIR | Nov 19, 2024 | 67.35 | +1.28 |
Abacus Life | ABL | Nov 19, 2024 | 8.43 | 0.00 |
Abbott Laboratories | ABT | Nov 19, 2024 | 117.13 | -0.20 |
AbbVie | ABBV | Nov 19, 2024 | 166.57 | +0.17 |
AbCellera Biologics | ABCL | Nov 19, 2024 | 2.71 | +2.26 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.